Trials / Sponsors / NanOlogy, LLC
NanOlogy, LLC
Industry · 11 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Trial of NanoPac Intratumoral Injection in Lung Cancer Lung Cancer, Nonsmall Cell, Lung Cancer, Lung Cancer, Small Cell | Phase 2 | 2021-04-14 |
| Terminated | Trial of NanoPac Focal Therapy for Prostate Cancer Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Adenocarcinoma | Phase 2 | 2020-10-20 |
| Withdrawn | Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma Renal Cell Carcinoma, Kidney Cancer, Adenocarcinoma of Kidney | Phase 1 | 2020-04-01 |
| Completed | Evaluation of NanoDoce® in Participants With Urothelial Carcinoma Bladder Cancer, Urothelial Carcinoma, Urinary Bladder Neoplasm | Phase 1 / Phase 2 | 2019-04-02 |
| Completed | Study of Topical SOR007 Ointment for Cutaneous Metastases Cutaneous Metastasis | Phase 1 / Phase 2 | 2018-01-31 |
| Completed | Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma Locally Advanced Pancreatic Adenocarcinoma | Phase 2 | 2017-12-01 |
| Completed | Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms Pancreatic Mucinous-Cystic Neoplasm | Phase 2 | 2017-09-29 |
| Completed | Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer Adenocarcinoma of the Prostate | Phase 2 | 2017-09-06 |
| Terminated | Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer Ovarian Carcinoma | Phase 2 | 2017-04-19 |
| No Longer Available | Expanded Access to NanoPac Locally Advanced Pancreatic Carcinoma, Prostate Cancer, Lung Cancer | — | — |
| No Longer Available | Expanded Access to NanoDoce Urogenital Neoplasms | — | — |